Awadhesh Kumar Singh

10PUBLICATIONS
29CO-AUTHORS
Nanotoxicology, health and safetyPharmacogenomicsEndocrinologyHaematological tumoursMolecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 08, 2026
Short-Term HbA1c Non-Inferiority of Synthetic Semaglutide Should Not Be Conflated With Full Therapeutic Interchangeability.

|Jan 11, 2026
Efficacy and safety of fixed-dose dapagliflozin-pioglitazone in Indian adults with type 2 diabetes: a phase 3 PRO-1 trial.

Awadhesh Kumar Singh, Krishna G Seshadri, A G Unnikrishnan

|Mar 12, 2024
An overview of therapeutic options of obesity management in India: the Integrated Diabetes and Endocrinology Academy (IDEA) 2023 Congress update.

Subir Ray, Nitin Kapoor, Neeta Deshpande

|Jan 23, 2023
Noninsulin-based antihyperglycemic medications in patients with diabetes and COVID-19: A systematic review and meta-analysis.

Mahmoud Nassar, Hazem Abosheaishaa, Awadhesh Kumar Singh

|Nov 25, 2022
Diagnostic approach in 46, XY DSD: an endocrine society of bengal (ESB) consensus statement.

Arjun Baidya, Asish Kumar Basu, Rana Bhattacharjee

|Feb 04, 2022
Letter by Awadhesh Kumar Singh Regarding Article, "Cardiovascular Outcomes Comparison of Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylurea as Add-on Therapy for Type 2 Diabetes Mellitus: A Meta-Analysis".

Awadhesh Kumar Singh, Ritu Singh

Pageof 2

Frequent Collaborators

4 joint publications

Ritu Singh

2 joint publications

Anoop Misra

1 joint publications

Clare L Gillies

1 joint publications

Sam Seidu